IP Library Granted Patent US 8,536,346
Granted Patent B2
US 8,536,346 · App. 13/243,001 · Granted Sep 17, 2013

Process or making N-hydroxy-3[4-[[[2-(2methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide and starting materials therefor

Inventors: Murat Acemoglu (Basel, CH); Joginder S. Bajwa (Elmwood Park, NJ); David John Parker (West Milford, NJ); Joel Slade (Flanders, NJ)
Assignee: Novartis AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,536,346
App. No.
13/243,001
Granted
Sep 17, 2013
Kind
B2
Abstract

N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide and starting materials therefore are prepared by new synthetic methods.

Claims (14)

1. A method of making N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide comprising:

(a) combining 2-methyltryptamine and (E)-3-(4-formyl-phenyl)-acrylic acid methyl ester to form an admixture;

(b) stirring the admixture;

(c) cooling the admixture;

(d) reducing the admixture;

(e) adding hydrochloric acid to the admixture to form the (E)-3-(4-{[2-(2-methyl-1H-indol-3-yl)-ethylamino]-methyl]-phenyl)-acrylic acid methyl ester hydrochloride salt;

(f) combining sodium hydroxide and (E)-3-(4-{[2-(2-methyl-1H-indol-3-yl)-ethylamino]-methyl]-phenyl)-acrylic acid methyl ester hydrochloride salt to form an admixture at a temperature of less than about −10° C.; and subsequently

(g) adding hydroxylamine to the admixture to form the N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide.

2. The method of claim 1 , wherein the (b) stirring occurs at a temperature range of from about 20° C. to about 25° C.

3. The method of claim 1 , wherein the admixture is cooled in (c) to a temperature of about −15° C.

4. The method of claim 1 , wherein reducing (d) is by the addition of sodium borohydride to the admixture.

5. The method of claim 4 , wherein the sodium borohydride is added while the temperature is maintained at a range from about −15° C. to about −10° C.

6. The method of claim 1 , wherein the temperature of (f) is less than about −15° C.

7. The method of claim 1 , wherein the hydroxylamine is used in an amount ranging from about 4 to about 13 equivalents.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2023
From: SECURA BIO, INC.
To: PHARMA& SCHWEIZ GMBH
Reel/Frame 063992/0870 →
RELEASE OF IP SECURITY INTEREST AT REEL/FRAME 048510/0364 Recorded Oct 31, 2022
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: SECURA BIO, INC.
Reel/Frame 061814/0821 →
CONFIRMATORY ASSIGNMENT Recorded May 21, 2019
From: NOVARTIS AG
To: SECURA BIO, INC.
Reel/Frame 049246/0720 →
SECURITY INTEREST Recorded Mar 5, 2019
From: SECURA BIO, INC.
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 048510/0364 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2019
From: NOVARTIS PHARMA AG
To: SECURA BIO, INC.
Reel/Frame 048477/0661 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2013
From: ACEMOGLU, MURAT; BAJWA, JOGINDER S.; PARKER, DAVID JOHN; SLADE, JOEL
To: NOVARTIS AG
Reel/Frame 030482/0210 →
Continuity (4)
Continuation 12302572
Provisional Application 60867878 · Nov 30, 2006
Provisional Application 60804527 · Jun 12, 2006
Related Publication 20120010418A1 · Jan 12, 2012